"The Child Autism Study using the Mente Autism device is one of the most exciting investigations this year. The changes observed in autistic children after a 12-week clinical trial are outstanding with many of the children with autism scoring in a normal range after the treatment. We are thrilled to review these incredible preliminary findings and are looking forward to the publication of the final study outcomes."
They have cash in bank, distribution channels in place and now outstanding clinical results ..
Suppose with a 100% rally, there will always be some loose stock, but jeeze it seems like they are gifting away stock right now
NTI Price at posting:
27.5¢ Sentiment: Buy Disclosure: Held
